HbA(1c) and Coronary Heart Disease Risk Among Diabetic Patients

OBJECTIVE: Clinical trials to date have not provided definitive evidence regarding the effects of glucose lowering with coronary heart disease (CHD) risk among diabetic patients. RESEARCH DESIGN AND METHODS: We prospectively investigated the association of HbA(1c) at baseline and during follow-up wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Wenhui, Katzmarzyk, Peter T., Horswell, Ronald, Wang, Yujie, Johnson, Jolene, Hu, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179505/
https://www.ncbi.nlm.nih.gov/pubmed/24130365
http://dx.doi.org/10.2337/dc13-1525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179505/
https://www.ncbi.nlm.nih.gov/pubmed/24130365
http://dx.doi.org/10.2337/dc13-1525

Ejemplares similares